课题基金 / 基金详情

Nano-delivery of novel inhibitors of polynucleotide kinase/phosphatase (PNKP) for tumor targeted sensitization of colorectal cancer to DNA damage.

Nano-delivery of novel inhibitors of polynucleotide kinase/phosphatase (PNKP) for tumor targeted sensitization of colorectal cancer to DNA damage.
纳米递送新型多核苷酸激酶/磷酸酶 (PNKP) 抑制剂，用于肿瘤靶向增敏结直肠癌对 DNA 损伤的作用。
批准号：
383393
负责人：
Sadat Sams M
金额：
$7.65万
依托单位：
University of Alberta
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2017
资助国家：
加拿大
项目状态：
已结题
起止时间：
2017-10-01 至 2020-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=383393&lang=en
关键词：
Cancer Therapy Colorectal Cancer Dna Repair Drug Delivery System Drug Resistance Human Polynucleotide Kinase/Phosphatase (Pnkp) Nanotechnology Pnkp Inhibitor Sensitization For Permanent Dna Damage Targeted Nanoparticle

项目摘要

项目成果

Sadat Sams M的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Colorectal cancer (CC) is the 4th most common cause of cancer-associated death worldwide. Surgery, chemotherapy (CT), and radiotherapy (RT) are the most common treatments for CC. However, these treatments are rarely curative and cause severe side effects
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Nano-delivery systmes for targeted co-delivery of topoisomerase toxin SN-38 and its novel synergistic inhibitor of DNA repair in colorectal cancer.
海外基金